Name: Sheryl Ann B.
Pedines BSN IV
Generic Name: Silver sulfadiazine
Brand Name: Silvadene
Dose/ Route/Frequency: topical BID
Mechanism of Action: Works by stopping the growth
of bacteria that may infect an open wound. This helps to
decrease the risk of the bacteria spreading to
surrounding skin, or to the blood where it can cause a
serious blood infection (sepsis)
Classification: Anti-microbial, sulfa antibiotics
Date: June 09, 2021
Nursing Responsibilities
Action Rationale
1. Verify the Doctor’s order. To ensure that this is the drug of choice for the
patient.
2. Consider the 10 rights of drug To prevent medical error.
administration.
3. Explain the purpose of the drug. To gain cooperation and promote compliances.
4. Maintain sterility when preparing and To minimizes wound contamination and reduces the
administering the medication. patient's risks for infections.
5. Contraindicated in patient with G6PD To prevent hemolysis to occur.
deficiency
7. Assess if allergic to it or to other sulfa The product may contain inactive ingredients, which
antibiotics (such as sulfamethoxazole); can cause allergic reactions or other problems.
or if have any other allergies.
8. Check for blood dyscrasias, Possible adverse reaction associated with
dermatologic and allergic reactions sulfonamides
(including life-threatening cutaneous
reactions [Stevens-Johnson syndrome
(SJS), toxic epidermal necrolysis
(TEN), exfoliative dermatitis]), GI
reactions, hepatitis and hepatocellular
necrosis, CNS reactions, and toxic
nephrosis
9. Instruct patient to report immediately if For early interventions.
occurrence of marked blistering,
peeling, or loosening of the skin,
itching, localized eruption of the skin,
|1
 transient skin discoloration, burning
sensation
10. Monitor therapeutic effectiveness of the To evaluate the therapeutic efficacy.
drug
11. Document and record. For references.
*side/adverse effect must be incorporated in the nursing intervention.

|2
Name: Sheryl Ann B. Pedines
Generic Name: Ketorolac
Brand Name: Toradol
Dose/ Route/Frequency: 1 amp IV
8h
Mechanism of action: Interferes
with prostaglandin biosynthesis by
inhibiting cyclooxygenase pathway
of arachidonic acid metabolism; also
acts as potent inhibitor of platelet
aggregations
Classification: Nonsteroidal anti-
inflammatory agent, Nonopioid
analgesics
Date: June 09, 2021
Nursing Responsibilities
Action Rationale
1. Verify the Doctor’s order. To ensure that this is the drug of choice for the
patient.
2. Consider the 10 rights of drug administration. To prevent medical error.
3. Explain the purpose of the drug. To gain cooperation and promote compliances.
4. Monitor for adverse reactions such as Fever, blisters, Drug may cause inhibitor of platelet aggregation
unexplained weight gain, shortness of breath or difficulty with a theoretical increased bleeding risk
breathing, swelling in the abdomen, ankles, feet, or legs,
yellowing of the skin or eyes, excessive tiredness, unusual
bleeding or bruising, lack of energy, nausea, loss of
appetite, pain in the upper right part of the stomach, flu-
like symptoms, pale skin, fast heartbeat, cloudy,
discolored, or bloody urine, back pain, difficult or painful
urination, especially prolonged bleeding time and CNS
reactions.
5. Monitor fluid intake and output. Drug may cause kidney failure
6. Inform patient that drug is meant only for short-term pain To allay anxiety.
management.
7. Advise patient by eating small, frequent servings of To minimize GI upset.
healthy foods.
8. Instruct patient to avoid aspirin products and herbs during Combining these medications may increase the risk
therapy. of side effects in the gastrointestinal tract such as
inflammation, bleeding, ulceration, and rarely,
perforation.
|3
 9. Used cautiously in patient with advanced renal impairment Drug may cause kidney failure
and patients at risk for renal failure.
10. Used cautiously in patients with suspected or confirmed Drug inhibits platelet function
cerebrovascular bleeding, hemorrhagic diathesis,
incomplete hemostasis, or high risk of bleeding.
11. Monitor therapeutic effectiveness of the drug To evaluate the therapeutic efficacy.
12. Document and record. For references.
*side/adverse effect must be incorporated in the nursing intervention.

|4